Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Pineal Research|January 29, 2013
Long-term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle-aged Ts65Dn mice, a model of Down syndromeAndrea Corrales, Paula Martínez, Susana García, et al.
Plos One|September 5, 2014
Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of Down syndromeSusana García-Cerro, Paula Martínez, Verónica Vidal, et al.
Neurochemical Research|July 25, 2016
Chronic Melatonin Administration Reduced Oxidative Damage and Cellular Senescence in the Hippocampus of a Mouse Model of Down SyndromeEduardo B Parisotto, Verónica Vidal, Susana García-Cerro, et al.
Neurobiology of Disease|December 10, 2017
Cerebellar alterations in a model of Down syndrome: The role of the Dyrk1A geneSusana García-Cerro, Verónica Vidal, Sara Lantigua, et al.
The Journal of Nutrition|April 4, 2020
Prenatal Administration of Oleic Acid or Linolenic Acid Reduces Neuromorphological and Cognitive Alterations in Ts65dn Down Syndrome MiceSusana García-Cerro, Noemí Rueda, Verónica Vidal, et al.
Molecular Neurobiology|July 19, 2017
Decreasing the Expression of GABAA α5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down SyndromeVerónica Vidal, Susana García-Cerro, Paula Martínez, et al.
Journal of Pineal Research|October 24, 2013
Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of Down syndromeAndrea Corrales, Rebeca Vidal, Susana García, et al.
Behavioural Brain Research|July 27, 2017
Pre- and post-natal melatonin administration partially regulates brain oxidative stress but does not improve cognitive or histological alterations in the Ts65Dn mouse model of Down syndromeAndrea Corrales, Eduardo B Parisotto, Verónica Vidal, et al.
Brain, Behavior, and Immunity|May 15, 2018
Anti-IL17 treatment ameliorates Down syndrome phenotypes in miceNoemí Rueda, Verónica Vidal, Susana García-Cerro, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 1, 2013
Reducing GABAA α5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndromeCarmen Martínez-Cué, Paula Martínez, Noemí Rueda, et al.
Pageof 3